|
End-of-day quote
NSE India S.E.
08/09/2026
|
5-day change | 1st Jan Change | ||
| 915.65 INR | +0.72% |
|
+14.70% | +21.84% |
| 08-14 | Supriya Lifescience Limited, Q1 2027 Earnings Call, Aug 14, 2026 | |
| 08-13 | Supriya Lifescience Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 | CI |
| Market Cap | 73.69B 777M 668M 629M 574M 1.07B 1.08B 7.45B 2.88B 37.67B 2.92B 2.86B 120B | P/E 2026 |
21.6x | P/E 2027 * | 31x |
|---|---|---|---|---|---|
| Enterprise Value | 73.69B 777M 668M 629M 574M 1.07B 1.08B 7.45B 2.88B 37.67B 2.92B 2.86B 120B | EV / Sales 2026 |
5.46x | EV / Sales 2027 * | 7.42x |
| Free-Float |
28.72% | Yield 2026 * |
-
| Yield 2027 * | - |
NSE India S.E.INR
| Markets | Quality | ||
|---|---|---|---|
NSE India S.E.
| SUPRIYA | End-of-day quote | |
Bombay S.E.
| SUPRIYA | Delayed |
Last Transcript : Supriya Lifescience Limited
| 1 day | +0.72% | ||
| 1 week | +14.70% | ||
| Current month | +14.70% | ||
| 1 month | -0.84% | ||
| 3 months | -3.41% | ||
| 6 months | +45.83% | ||
| Current year | +21.84% |
| 1 week | 800 |  | 925.1 |
| 1 month | 740.45 | | 940 |
| Current year | 545.5 | | 1,085 |
| 1 year | 545.5 | | 1,085 |
| 3 years | 234.9 | | 1,085 |
| 5 years | 170.15 | | 1,085 |
| 10 years | 170.15 | | 1,085 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 35 | 01/08/2024 | |
| Chief Executive Officer | 36 | 01/08/2024 | |
| Director of Finance/CFO | - | 23/01/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 74 | 24/01/2025 | |
| Director/Board Member | 67 | 25/03/2021 | |
| Chairman | 70 | 26/03/2008 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.72% | +14.70% | +40.53% | +211.02% | 774M | |
| -2.21% | -3.11% | +52.16% | +91.64% | 1,024B | |
| -2.22% | -0.76% | +51.08% | +67.61% | 663B | |
| -2.99% | -4.31% | +18.59% | +66.94% | 453B | |
| -0.88% | -0.65% | +27.83% | +36.57% | 349B | |
| -10.89% | -9.30% | +7.52% | +26.14% | 295B | |
| -1.38% | -0.79% | -1.77% | +9.72% | 253B | |
| -10.08% | -10.26% | +40.32% | +51.55% | 236B | |
| -2.32% | -0.14% | -16.57% | -56.82% | 206B | |
| -2.88% | -2.19% | +26.54% | +92.95% | 187B | |
| Average | -3.38% | +1.94% | +24.62% | +59.73% | 366.81B | |
| Weighted average by Cap. | -3.22% | +0.52% | +32.26% | +57.27% |
| 2026 | 2027 * | |
|---|---|---|
| Net sales | 8.4B 88.6M 76.18M 71.67M 65.41M 122M 123M 849M 329M 4.29B 333M 325M 13.66B | 9.94B 105M 90.1M 84.77M 77.36M 144M 145M 1B 389M 5.08B 394M 385M 16.16B |
| Net income | 2B 21.11M 18.15M 17.07M 15.58M 29.08M 29.23M 202M 78.26M 1.02B 79.26M 77.53M 3.25B | 2.37B 25.02M 21.51M 20.24M 18.47M 34.47M 34.65M 240M 92.77M 1.21B 93.95M 91.9M 3.86B |
| Net Debt | - | - |
Employees
515
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 08/09/26 | ₹915.65 | +0.72% | 265,504 |
| 07/09/26 | ₹909.10 | +6.60% | 1,225,649 |
| 04/09/26 | ₹852.85 | +1.20% | 324,059 |
| 03/09/26 | ₹842.70 | +0.18% | 195,699 |
| 02/09/26 | ₹841.20 | +4.74% | 960,564 |
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SUPRIYA Stock
Select your edition
All financial news and data tailored to specific country editions
